Early Calibration of TRAABA24 Shows Promising Initial Results in PMP
Preclinical Study Progress Update Share This Article: Early Calibration of TRAABA24 Lipid Nanoparticle Show Promising Initial Results in PMP. Over the last few weeks we initiated the calibration of lab conditions to ensure consistency and accuracy in our preclinical studies. As part of this process, we conducted initial testing of TRAABA24 encapsulated in a lipid […]
Successful Culturing of Primary Cells for PMP Research
Milestone Update Share This Article: Successful Culturing of Primary Cells for PMP Research In December 2024, thanks to collaboration with researchers at the University of South Carolina, Bina Therapeutics achieved a significant milestone by establishing a master cell bank for our Pseudomyxoma Peritonei (PMP) research. As we begin 2025, we are pleased to share the […]
Bina Therapeutics establishes a master cell bank for PMP research
Milestone Update Share This Article: Establishment PMP Cell Culture Collection As part of our commitment to keeping you informed, we’re thrilled to announce that Bina Therapeutics has established its master cell bank for development! Thanks to the generosity and relentless support of our collaborative partners, the preclinical validation of TRAABA24 can now begin. Pseudomyxoma Peritonei (PMP) is […]
